Ozempic is a medication used to treat type 2 diabetes. It is a GLP-1 receptor agonist, which means that it mimics the effects of a hormone called glucagon-like peptide-1 (GLP-1) in the body. GLP-1 is normally released by the intestines after a meal and stimulates the pancreas to produce insulin, which helps to lower blood sugar levels.

Ozempic works by binding to the GLP-1 receptors in the body, which leads to an increase in insulin secretion and a decrease in glucagon secretion. Glucagon is a hormone that raises blood sugar levels, so by reducing its secretion, Ozempic helps to lower blood sugar levels. Additionally, Ozempic slows down the rate at which food is digested and absorbed in the intestines, which helps to prevent spikes in blood sugar levels after meals.

According to Drugs.com [3], Ozempic has a long half-life of about 5 weeks, which means that it stays in the body for a relatively long time. This allows for once-weekly dosing, which can help to improve medication adherence and make it easier for patients to manage their diabetes.

In summary, Ozempic works by mimicking the effects of GLP-1 in the body, which leads to an increase in insulin secretion, a decrease in glucagon secretion, and a slowing down of the rate of food absorption in the intestines. Its long half-life allows for once-weekly dosing, which can improve medication adherence.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/OZEMPIC
[2] https://www.ozempic.com/why-ozempic/how-ozempic-works.html
[3] https://www.drugs.com/medical-answers/long-ozempic-work-3543031/